Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Vasopressor Selection and Administration in Septic Shock
FY 2020-21
Summary
Septic shock is infection that overwhelms the body with low blood pressure and is associated with a very high possibility of death in the hospital (40-50%). These patients receive fluids and antibiotics for treatment. As well, they receive medications called vasopressors (such as norepinephrine) that are infusions into the vein to keep the blood pressure up. But vasopressors themselves carry risks, such as causing abnormal heart rhythms and lack of oxygen to parts of the body that can result in death. Guidelines for the use of vasopressors recommend norepinephrine as the first one to use for care of patients with septic shock. However, it is unknown how often norepinephrine is used as the first choice in Canada and what factors might be associated with failure to use it as recommended by guidelines. Additionally, there is uncertainty about whether special catheters called central venous catheters are needed to deliver norepinephrine. On the one hand, these catheters remove risk of damage to veins in the arms and surrounding tissues, however, they have their own risks including bloodstream infection, bleeding and damage to the lungs during placement. To address these concerns, I will use detailed data from Alberta that includes information on vasopressor use and other information about patients and their care. I will look at variation in use of norepinephrine for patients with septic shock and will determine whether the presence of a central venous catheter influences vasopressor choice. I will also perform a decision analysis examining whether doctors should place central venous catheters for use of norepinephrine, weighing the risks and benefits. This work will 1) identify variation in what medication for blood pressure doctors choose and 2) identify the best way for norepinephrine to be given. Since many people get septic shock every year and there is a high death rate, this study is important, and may have a large impact on patients' care in Canada and worldwide.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
439377
Name
Teja Bijan J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Vasopressor Selection and Administration in Septic Shock
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Outcomes; Pharmaco-Epidemiology; Septic Shock; Vasopressors
Abstract
Septic shock is infection that overwhelms the body with low blood pressure and is associated with a very high possibility of death in the hospital (40-50%). These patients receive fluids and antibiotics for treatment. As well, they receive medications called vasopressors (such as norepinephrine) that are infusions into the vein to keep the blood pressure up. But vasopressors themselves carry risks, such as causing abnormal heart rhythms and lack of oxygen to parts of the body that can result in death. Guidelines for the use of vasopressors recommend norepinephrine as the first one to use for care of patients with septic shock. However, it is unknown how often norepinephrine is used as the first choice in Canada and what factors might be associated with failure to use it as recommended by guidelines. Additionally, there is uncertainty about whether special catheters called central venous catheters are needed to deliver norepinephrine. On the one hand, these catheters remove risk of damage to veins in the arms and surrounding tissues, however, they have their own risks including bloodstream infection, bleeding and damage to the lungs during placement. To address these concerns, I will use detailed data from Alberta that includes information on vasopressor use and other information about patients and their care. I will look at variation in use of norepinephrine for patients with septic shock and will determine whether the presence of a central venous catheter influences vasopressor choice. I will also perform a decision analysis examining whether doctors should place central venous catheters for use of norepinephrine, weighing the risks and benefits. This work will 1) identify variation in what medication for blood pressure doctors choose and 2) identify the best way for norepinephrine to be given. Since many people get septic shock every year and there is a high death rate, this study is important, and may have a large impact on patients' care in Canada and worldwide.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Teja, Bijan J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~